Aug. 22 at 3:37 PM
$LLY $SNDQ $CSCO $AMP $PFE Eli Lilly benefits from strong obesity and diabetes-drug demand, SNDQ remains tied to semiconductor and technology momentum, Cisco benefits from networking and AI infrastructure, Ameriprise benefits from wealth-management demand, and Pfizer remains focused on its pharmaceutical pipeline. I'm watching prescription growth, chip momentum, networking orders, asset flows, and clinical catalysts.